TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
AGB-Pharma AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
126,540
|
170,136
|
161,875 |
| Financial expenses |
1,326
|
535
|
5 |
| Earnings before taxes |
3,758
|
56,541
|
82,775 |
| EBITDA |
1,576
|
54,569
|
81,843 |
| Total assets |
62,525
|
124,209
|
119,526 |
| Current assets |
55,352
|
117,384
|
114,219 |
| Current liabilities |
29,912
|
54,586
|
35,873 |
| Equity capital |
27,027
|
65,075
|
80,678 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
20
|
17
|
11 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
43.2%
|
52.4%
|
67.5% |
| Turnover per employee |
6,327
|
10,008
|
14,716 |
| Profit as a percentage of turnover |
3.0%
|
33.2%
|
51.1% |
| Return on assets (ROA) |
8.1%
|
46.0%
|
69.3% |
| Current ratio |
185.0%
|
215.0%
|
318.4% |
| Return on equity (ROE) |
13.9%
|
86.9%
|
102.6% |
| Change turnover |
-37,969
|
7,427
|
50,595 |
| Change turnover % |
-23%
|
5%
|
45% |
| Chg. No. of employees |
3
|
6
|
5 |
| Chg. No. of employees % |
18%
|
55%
|
83% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.